Results 71 to 80 of about 20,763 (194)

Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the peruvian national institute of neoplastic diseases

open access: yesRevista Peruana de Medicina Experimental y Salud Pública, 2018
Objectives. To determine the rate of optimal cytoreduction in patients with advanced ovarian cancer who received neoadjuvant chemotherapy with dose-dense carboplatin and paclitaxel followed by interval debulking surgery (IDS). Materials and Methods.
Cindy Alcarraz   +8 more
doaj   +1 more source

Safety and Efficacy of Pre-Cytoreduction Prior to Definitive Multi-Agent Chemotherapy in Aggressive Lymphoma

open access: yesPakistan Journal of Medicine and Dentistry
Background: Pre-cytoreduction refers to the administration of initial chemotherapy to reduce tumor burden prior to initiating definitive multi-agent chemotherapy.
Reena Kumari Sunil   +3 more
doaj   +1 more source

Peran Serum IL-6 dan CA-125 Prabedah sebagai Prediktor Resektabilitas Tumor pada Kanker Ovarium Tipe Epitel [PDF]

open access: yes, 2017
Keberhasilan terapi kanker ovarium ditentukan oleh optimalnya sitoreduksi yang dilakukan sebelum pemberian kemoterapi. Maksimal residual tumor setelah sitoreduksi dan sebelum kemoterapi sangat penting untuk prognosis.
HIDAYAT, Y. M. (YUDI)   +5 more
core  

Transcriptome signature for the identification of bevacizumab responders in ovarian cancer [PDF]

open access: yesarXiv
The standard of care for ovarian cancer comprises cytoreductive surgery, followed by adjuvant platinum-based chemotherapy plus taxane therapy and maintenance therapy with the antiangiogenic compound bevacizumab and/or a PARP inhibitor. Nevertheless, there is currently no clear clinical indication for the use of bevacizumab, highlighting the urgent need
arxiv  

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases [PDF]

open access: bronze, 1998
Shimon Slavin   +14 more
openalex   +1 more source

Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency [PDF]

open access: bronze, 2001
Ronald J. Rubocki   +9 more
openalex   +1 more source

Successful Cytoreduction with CAG (cytarabine, Aclarubicin and G-CSF) Therapy in Refractory Acute Myelogenous Leukemia before Allogeneic Stem Cell Transplantation [PDF]

open access: bronze, 2001
Tohru Murayama   +7 more
openalex   +1 more source

Patterns and predictors of outpatient opioid use after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

open access: yesInternational Journal of Hyperthermia, 2019
Background: Long-term opioid use is a well-known complication after surgery. In this retrospective study of adults who had undergone cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), we sought to determine the rates and ...
Pascal Owusu-Agyemang   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy